Potential use of nucleic acid-based agents in the sensitization of nasopharyngeal carcinoma to radiotherapy

Lu Zhang, Lifang Yang, Jian-Jian Li, Lunquan Sun

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Nasopharyngeal carcinoma (NPC) is a highly metastatic cancer. The 2-year survival rate of patients with stage III or IV disease is only about 50%. Due to its high radiosensitivity, radiotherapy is the standard treatment for early-stage of NPC. However, the radioresistance observed in some patients can cause distant metastases and local recurrence after radiotherapy. Special emphasis has been given to the discovery of effective radiosensitizers. Oncogenic proteins encoded by EBV genomes may serve as part of targeted radiosensitization, such as NF k{cyrillic}B-mediated expression of latent membrane protein-1. We here review the major nucleic acid-based options currently used in cancer therapeutic approaches and the selected candidate genes that can be targeted for NPC radiosensitization.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalCancer Letters
Volume323
Issue number1
DOIs
StatePublished - Oct 1 2012

Fingerprint

Nucleic Acids
Radiotherapy
Radiation Tolerance
Human Herpesvirus 4
Neoplasms
Membrane Proteins
Survival Rate
Genome
Neoplasm Metastasis
Recurrence
Therapeutics
Genes
Nasopharyngeal carcinoma
Proteins

Keywords

  • Nasopharyngeal carcinoma
  • Nucleic acid-based agents
  • Radiotherapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Potential use of nucleic acid-based agents in the sensitization of nasopharyngeal carcinoma to radiotherapy. / Zhang, Lu; Yang, Lifang; Li, Jian-Jian; Sun, Lunquan.

In: Cancer Letters, Vol. 323, No. 1, 01.10.2012, p. 1-10.

Research output: Contribution to journalArticle

@article{6d0550a36a0c403c8e3b1e08b2b37862,
title = "Potential use of nucleic acid-based agents in the sensitization of nasopharyngeal carcinoma to radiotherapy",
abstract = "Nasopharyngeal carcinoma (NPC) is a highly metastatic cancer. The 2-year survival rate of patients with stage III or IV disease is only about 50{\%}. Due to its high radiosensitivity, radiotherapy is the standard treatment for early-stage of NPC. However, the radioresistance observed in some patients can cause distant metastases and local recurrence after radiotherapy. Special emphasis has been given to the discovery of effective radiosensitizers. Oncogenic proteins encoded by EBV genomes may serve as part of targeted radiosensitization, such as NF k{cyrillic}B-mediated expression of latent membrane protein-1. We here review the major nucleic acid-based options currently used in cancer therapeutic approaches and the selected candidate genes that can be targeted for NPC radiosensitization.",
keywords = "Nasopharyngeal carcinoma, Nucleic acid-based agents, Radiotherapy",
author = "Lu Zhang and Lifang Yang and Jian-Jian Li and Lunquan Sun",
year = "2012",
month = "10",
day = "1",
doi = "10.1016/j.canlet.2012.03.030",
language = "English (US)",
volume = "323",
pages = "1--10",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Potential use of nucleic acid-based agents in the sensitization of nasopharyngeal carcinoma to radiotherapy

AU - Zhang, Lu

AU - Yang, Lifang

AU - Li, Jian-Jian

AU - Sun, Lunquan

PY - 2012/10/1

Y1 - 2012/10/1

N2 - Nasopharyngeal carcinoma (NPC) is a highly metastatic cancer. The 2-year survival rate of patients with stage III or IV disease is only about 50%. Due to its high radiosensitivity, radiotherapy is the standard treatment for early-stage of NPC. However, the radioresistance observed in some patients can cause distant metastases and local recurrence after radiotherapy. Special emphasis has been given to the discovery of effective radiosensitizers. Oncogenic proteins encoded by EBV genomes may serve as part of targeted radiosensitization, such as NF k{cyrillic}B-mediated expression of latent membrane protein-1. We here review the major nucleic acid-based options currently used in cancer therapeutic approaches and the selected candidate genes that can be targeted for NPC radiosensitization.

AB - Nasopharyngeal carcinoma (NPC) is a highly metastatic cancer. The 2-year survival rate of patients with stage III or IV disease is only about 50%. Due to its high radiosensitivity, radiotherapy is the standard treatment for early-stage of NPC. However, the radioresistance observed in some patients can cause distant metastases and local recurrence after radiotherapy. Special emphasis has been given to the discovery of effective radiosensitizers. Oncogenic proteins encoded by EBV genomes may serve as part of targeted radiosensitization, such as NF k{cyrillic}B-mediated expression of latent membrane protein-1. We here review the major nucleic acid-based options currently used in cancer therapeutic approaches and the selected candidate genes that can be targeted for NPC radiosensitization.

KW - Nasopharyngeal carcinoma

KW - Nucleic acid-based agents

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=84861815530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861815530&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2012.03.030

DO - 10.1016/j.canlet.2012.03.030

M3 - Article

VL - 323

SP - 1

EP - 10

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 1

ER -